Cell and Gene Commercialization
-
Supporting Bench To Production Applications For Multiple Industries
10/17/2023
Grow and scale up your manufacturing with the right support, and choose from 92,000+ chemicals provided through an extensive global network of 3,500+ manufacturers.
-
Build Support In The Early Days Of Advanced Therapy Entrepreneurship
10/12/2023
While more biotech companies are entering the market, advanced therapy startups can still benefit greatly from product and service options that help address challenges in the MSC or EV / exosome space.
-
The Future Of Cell And Organ Transplantation In Treating T1D With Dr. Camillo Ricordi
10/10/2023
Explore the biggest and most troubling challenges facing the treatment of Type 1 Diabetes (T1D) and the future of cell and organ transplantation in treating T1D as well as the latest innovations in biopreservation.
-
Webinar: Reimbursement Methods For Sustainable CGT Business Models
10/10/2023
Learn more about the key features of successful innovative pricing and reimbursement models as well as outcomes-based agreements and the ways to advance those strategies for cell and gene therapies.
-
Essential Guide To Cell And Gene Therapy Commercialization
10/10/2023
After devoting time, expertise, and financial resources to developing a transformative cell or gene therapy, it is essential to ensure patients can receive all of the benefits of your innovation.
-
Improving Access And Support For Cell And Gene Therapies
10/9/2023
Although cell and gene therapies (CGTs) are potentially transformative, their effectiveness is undermined by difficulties with patient access and support, high costs, and a complex pathway to treatment.
-
Scaling Hope: Growth Of The Allogeneic Cell Therapy Sector
10/6/2023
By utilizing cells from donors which are then modified and stored in large batches, allogeneic therapies enable accelerated timelines and larger-scale preparation.
-
Demonstrating Value to Payers: Ensuring Patient Access To CGTs
10/6/2023
A comprehensive approach that provides clinical evidence of efficacy and safety, demonstrates cost-effectiveness, and focuses on the patient perspective is essential in building a strong value proposition.
-
Creating A Sustainable Business Model For Cell And Gene Therapies
10/5/2023
Avoid product launch delays and expand patient access to CGTs by understanding and meeting regulatory guidelines and securing approval for reimbursement of treatment costs.
-
The New Economics Of Cell And Gene Therapy
10/5/2023
The authors explain why we are seeing more withdrawals than blockbusters and what we should do about it.